Rhythm Pharmaceuticals recently announced the publication of an updated, evidence-based diagnostic algorithm for Bardet-Biedl syndrome in the American Journal of Medical Genetics, aiming to help ...

Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced ...

A top-level international research team including researchers from the University of Eastern Finland has developed a new algorithm for the diagnostics of dementia. The algorithm is based on blood and ...

Please provide your email address to receive an email when new articles are posted on . AI algorithms to diagnose skin cancer had lower sensitivity and specificity when tested on a multimodal, ...

Up to 40% of rare diseases show facial alterations that enable researchers to identify some pathologies and they can even help them to establish an early diagnosis. Historically, the visual evaluation ...

This retrospective study evaluated real-world implementation of the updated CDC HIV algorithm in a large US laboratory. Objectives: To understand real-world implementation of the updated CDC HIV ...

Algorithms are not new to pediatric tuberculosis. Other scientists have created similar algorithms to enhance disease diagnosis, but Gunasekera explained that those algorithms have largely relied on ...

As the May 26th CE-IVDR compliance deadline comes into effect, Diagnostics.ai launches the industry's first fully-transparent machine learning platform for clinical real-time PCR diagnostics – ...